MEB Medibio

Medibio Market Update

Medibio Market Update

SYDNEY, Australia and MINNEAPOLIS, Minn., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Medibio Limited (MEB or the Company) (ASX: MEB)(OTCQB: MDBIF), a mental health technology company, today shares a market update to the recent quarterly update.

ISO 13485 Certification

This week the company completed the annual audit process for certification of the Company’s Quality Management System.  The audit was conducted by DQS Med, the Notified Body appointed to assess our compliance. There were no major or minor findings, providing further evidence of the stability of our quality system for design and manufacturing of medical devices. We are pleased with our team’s preparation for the audit process and their ability to deliver against this competency.

Staff Reductions

As previously disclosed, the Company has implemented cost reduction measures that included eliminating certain staff positions in Minneapolis, MN.  We thank those employees for their service and team contributions.

About Medibio Limited

Medibio (ASX: MEB) (OTCQB: MDBIF) is a mental health technology company that has pioneered the use of objective digital biomarkers to assist in the screening, diagnosing, monitoring and management of depression and other mental health conditions. The company was founded in Australia, with offices located in Melbourne (Vic), Perth (Wa) and U.S. offices in Minneapolis, MN. Medibio is listed on the Australian Securities Exchange Ltd and trades on the OTCQB Venture Market. Investors can find additional information on  and .

  
Further Information:

Website:
  
Medibio Enquiries:

Kristi Hamilton

Senior Marketing Communications Manager

Medibio Limited



T: 		Australian Media Enquiries:

Peter Taylor

NWR Communications



T: +61 (0) 412 036 231
  
EN
02/11/2018

Underlying

MEBMedibio

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Medibio

 PRESS RELEASE
Free
MEB MEDIBIO

Medibio Signs Insurance Company AIA Australia Ltd (AIAA) For an Exclus...

Medibio Signs Insurance Company AIA Australia Ltd (AIAA) For an Exclusive Pilot Program For ilumen™ SYDNEY, Australia and MINNEAPOLIS, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company announces that it has signed an exclusive agreement with AIAA to undertake a pilot program for the latest release of its corporate health program, ilumen™. AIAA is one of Australia’s leading life insurers, offering a range of products that protect the financial health and wellbeing of more than 4 million Australians.  AIAA is ...

November 27, 2018 1 EN
 PRESS RELEASE
Free
MEB MEDIBIO

Medibio Appoints Global Healthcare & Medical Device Leader as CEO and ...

Medibio Appoints Global Healthcare & Medical Device Leader as CEO and Managing Director SYDNEY, Australia and MINNEAPOLIS, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company, announces the appointment of David B. Kaysen as CEO and Managing Director. Mr. Kaysen brings more than 35 years of experience leading and managing both domestic and international emerging growth companies. He has achieved consistent and solid results with bio-pharmaceutical, medical device, and clinical software/IT companies. He is exper...

November 2, 2018 1 EN
 PRESS RELEASE
Free
MEB MEDIBIO

Medibio Market Update

Medibio Market Update SYDNEY, Australia and MINNEAPOLIS, Minn., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Medibio Limited (MEB or the Company) (ASX: MEB)(OTCQB: MDBIF), a mental health technology company, today shares a market update to the recent quarterly update. ISO 13485 CertificationThis week the company completed the annual audit process for certification of the Company’s Quality Management System.  The audit was conducted by DQS Med, the Notified Body appointed to assess our compliance. There were no major or minor findings, providing further evidence of the stability of our quality s...

November 2, 2018 1 EN
 PRESS RELEASE
Free
MEB MEDIBIO

Medibio Limited Quarterly ASX Update and Cashflows

Medibio Limited Quarterly ASX Update and Cashflows Quarterly Update and Message from Medibio Limited SYDNEY, Australia and MINNEAPOLIS, Minn., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Medibio Limited (MEB or the Company) (ASX: MEB)(OTCQB: MDBIF), a mental health technology company provides the following quarterly update: Key highlights from the quarter Announced clinical study results - showing an improvement of more than 20% to current diagnostic standard- Achievement of 70% accuracy, 70% sensitivity and 71% specificity results - demonstrating utility as diagnostic aide and long-term monitor...

October 30, 2018 1 EN
 PRESS RELEASE
Free
MEB MEDIBIO

Medibio Signs ilumenâ„¢ Corporate Contract with a Large Australian Em...

Medibio Signs ilumen™ Corporate Contract with a Large Australian Employer SYDNEY, Australia and MINNEAPOLIS, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Medibio Limited (MEB or the Company) (ASX: MEB) (OTCQB: MDBIF), a mental health technology company, announces a contract for the latest release of its corporate health program, ilumen™. ilumen™ is unique to the corporate health market as it integrates unique and proprietary objective biometrics with subjective assessments. Users can access and monitor this data from their personal devices, measuring and tracking biometrics through the use of wear...

October 24, 2018 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch